NCT05301764 2024-10-15A Study of LVGN6051 Combined with Anlotinib in Patient with Soft Tissue SarcomaLyvgen Biopharma Holdings LimitedPhase 1/2 Recruiting65 enrolled
NCT06506838 2024-08-12Anlotinib Combined With Doxorubicin and Radiotherapy as Neoadjuvant Treatment for Soft Tissue SarcomaGuangdong Provincial People's HospitalPhase 4 Recruiting39 enrolled